BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8601662)

  • 1. Treatment of bullous pemphigoid with dapsone: retrospective study of thirty-six cases.
    Bouscarat F; Chosidow O; Picard-Dahan C; Sakiz V; Crickx B; Prost C; Roujeau JC; Revuz J; Belaich S
    J Am Acad Dermatol; 1996 Apr; 34(4):683-4. PubMed ID: 8601662
    [No Abstract]   [Full Text] [Related]  

  • 2. Pemphigoid and pemphigus foliaceus successfully treated with topical corticosteroids.
    Muramatsu T; Iida T; Shirai T
    J Dermatol; 1996 Oct; 23(10):683-8. PubMed ID: 8973033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of 16 patients with bullous pemphigoid with oral tetracycline and niacinamide and topical clobetasol.
    Hornschuh B; Hamm H; Wever S; Hashimoto T; Schröder U; Bröcker EB; Zillikens D
    J Am Acad Dermatol; 1997 Jan; 36(1):101-3. PubMed ID: 8996271
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases.
    Schmidt E; Kraensel R; Goebeler M; Sinkgraven R; Bröcker EB; Rzany B; Zillikens D
    Cutis; 2005 Sep; 76(3):205-9. PubMed ID: 16268266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of generalized bullous pemphigoid with topical corticosteroids.
    Spuls PI; Brakman M; Westerhof W; Bos JD
    Acta Derm Venereol; 1995 Jan; 75(1):89. PubMed ID: 7747552
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical corticosteroids and bullous pemphigoid.
    Hull CM; McKenna JK; Zone JJ
    Arch Dermatol; 2003 Feb; 139(2):225-6. PubMed ID: 12588236
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bullous pemphigoid: diagnostics and new therapeutic strategies].
    Hofmann SC; Bruckner-Tuderman L
    Dtsch Med Wochenschr; 2006 Feb; 131(8):389-92. PubMed ID: 16479471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prospective study of treatment of bullous pemphigoid by a class I topical corticosteroid].
    Zimmermann R; Faure M; Claudy A
    Ann Dermatol Venereol; 1999 Jan; 126(1):13-6. PubMed ID: 10095883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pemphigoid gestationis: treatment by topical class I corticosteroid].
    Valeyrie L; Lebrun-Vignes B; Bodak N; Grossin M; Descamps V; Crickx B; Bélaïch S
    Ann Dermatol Venereol; 2001 May; 128(5):638-40. PubMed ID: 11427799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective study of the management of oral mucous membrane pemphigoid with dapsone.
    Ciarrocca KN; Greenberg MS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Aug; 88(2):159-63. PubMed ID: 10468458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the safety and efficacy of a potent topical cortico-steroid in the treatment of bullous pemphigoid.
    Claudy A
    Clin Dermatol; 2001; 19(6):778-80. PubMed ID: 11705688
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of pemphigus and pemphigoids.
    López-Jornet P; Bermejo-Fenoll A
    Med Oral Patol Oral Cir Bucal; 2005; 10(5):410-1. PubMed ID: 16264376
    [No Abstract]   [Full Text] [Related]  

  • 13. [A startling beginning! Revolutionary local therapy of bullous pemphigoid?].
    Breit R
    Hautarzt; 2002 Jun; 53(6):439-40. PubMed ID: 12132304
    [No Abstract]   [Full Text] [Related]  

  • 14. Dapsone for the treatment of bullous pemphigoid.
    Piamphongsant T
    Asian Pac J Allergy Immunol; 1983 Jun; 1(1):19-21. PubMed ID: 6398078
    [No Abstract]   [Full Text] [Related]  

  • 15. Tetracycline, nicotinamide, and lesionally administered clobetasol as a therapeutic option to prednisone in patients with bullous pemphigoid: a comparative, retrospective analysis of 106 patients with long-term follow-up.
    Kalinska-Bienias A; Kowalczyk E; Jagielski P; Kowalewski C; Wozniak K
    Int J Dermatol; 2019 Feb; 58(2):172-177. PubMed ID: 30350359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bullous Pemphigoid in Infancy Showing Epitope-spreading Phenomenon: Recovery with Topical Therapy.
    Matsuda H; Oiso N; Ishii N; Sato M; Tatebayashi M; Hashimoto T; Kawada A
    Acta Derm Venereol; 2015 May; 95(5):610-1. PubMed ID: 25424244
    [No Abstract]   [Full Text] [Related]  

  • 17. Benign mucous membrane pemphigoid with advanced periodontal involvement: diagnosis and therapy.
    Lilly JP; Spivey JD; Fotos PG
    J Periodontol; 1995 Aug; 66(8):737-41. PubMed ID: 7473017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, biochemical and morphological responses of patients with villous atrophy to oral betamethasone valerate and clobetasone butyrate.
    Bramble MG; Watson AJ; Scott J; Peters TJ; Record CO
    Digestion; 1981; 22(6):281-8. PubMed ID: 7037504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open label study of clobetasol propionate 0.05% and betamethasone valerate 0.12% foams in the treatment of mild to moderate acne keloidalis.
    Callender VD; Young CM; Haverstock CL; Carroll CL; Feldman SR
    Cutis; 2005 Jun; 75(6):317-21. PubMed ID: 16047868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapsone as first line therapy for bullous pemphigoid.
    Venning VA; Millard PR; Wojnarowska F
    Br J Dermatol; 1989 Jan; 120(1):83-92. PubMed ID: 2700666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.